Chemotherapy

Chemotherapy is administered to a cancer patient via intravenous drip at Duke Cancer Center in Durham, N.C. (AP Photo/Gerry Broome)

New drug, study method show breast cancer promise

SAN ANTONIO (AP) — A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat […]

12/13/2013

FDA approves new leukemia drug from Roche

WASHINGTON (AP) — The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow. The agency cleared Gazyva […]

11/01/2013

(AP Photo)

FDA approves first pre-surgical breast cancer drug

WASHINGTON (AP) – A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease. The Food […]

09/30/2013

(AP Photo)

FDA says Roche drug works in early-stage breast cancer

WASHINGTON (AP) — The Food and Drug Administration has issued a positive review of a breast cancer drug from Roche that could soon become the first pharmaceutical option for treating the earliest stages of the […]

09/10/2013

FDA

FDA allows generic version of scarce cancer drug

WASHINGTON (AP) — Federal regulators say approval of the first generic version of cancer drug Doxil will help resolve a lingering shortage triggered by manufacturing deficiencies.

02/04/2013

Orange County Sheriff says she has breast cancer

SANTA ANA, Calif. (AP) — Orange County Sheriff Sandra Hutchens says she has breast cancer, but she will continue to work through her aggressive treatment plan. Hutchens said at a news conference Monday that she […]

11/27/2012

Study: Cancer patients overestimate value of chemo

NEW YORK (AP) – Most patients getting chemotherapy for incurable lung or colon cancers mistakenly believe that the treatment can cure them rather than just buy them some more time or ease their symptoms, a […]

10/24/2012